Group 1 - The core point of the article highlights that southbound funds have increased their holdings in Jinxin Reproductive Medicine (01951.HK) by 5.1485 million shares on September 23, 2025, marking a positive trend in investment interest [1] - Over the past five trading days, there have been four days of net increases in holdings by southbound funds, totaling 23.7135 million shares [1] - In the last twenty trading days, there were sixteen days of net increases, accumulating to 120 million shares [1] Group 2 - As of now, southbound funds hold a total of 1.416 billion shares of Jinxin Reproductive Medicine, which represents 51.33% of the company's issued ordinary shares [1] - The total number of shares held on September 23, 2025, was 1.416 billion, with a change of 0.36% from the previous day [2] - The company primarily provides in vitro fertilization (IVF) services and operates in China and the United States, offering a range of reproductive and medical services [2]
锦欣生殖（01951.HK）：9月23日南向资金增持514.85万股